160 Health International (FRA:O66) Beneish M-Score: -1.21 (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:O66 160 Health International Ltd FRA:O66
8 GF Score
Price €1.06
! 5 Warning Signs
View Full Analysis

What is 160 Health International Beneish M-Score?

160 Health International FRA:O66 -5.84% 8 Beneish M-Score is -1.21 as of Aug. 19, 2026. GuruFocus rates FRA:O66 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review. Among 116 Medical Distribution companies, 160 Health International ranks worse than 90.52% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.21 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for 160 Health International's Beneish M-Score or its related term are showing as below:

FRA:O66' s Beneish M-Score Range Over the Past 10 Years
Min: -3.89   Med: -2.55   Max: -1.21
Current: -1.21

During the past 4 years, the highest Beneish M-Score of 160 Health International was -1.21. The lowest was -3.89. And the median was -2.55.

160 Health International Beneish M-Score Historical Data

* Premium members only.

The historical data trend for 160 Health International's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

160 Health International Beneish M-Score Chart

160 Health International Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Beneish M-Score
0.00 0.00 -3.89 -1.21

160 Health International Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial 0.00 0.00 -3.89 0.00 -1.21

FRA:O66 vs MCK, COR, CAH: Beneish M-Score Comparison

For the Medical Distribution subindustry, 160 Health International's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

160 Health International Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, 160 Health International's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where 160 Health International's Beneish M-Score falls into.


FRA:O66
8GF Score
160 Health International Ltd FRA:O66
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

160 Health International Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of 160 Health International for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1089+0.528 * 0.9887+0.404 * 2.6701+0.892 * 0.9708+0.115 * 0.9761
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9112+4.679 * 0.054546-0.327 * 0.5333
=-1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was €25.02 Mil.
Revenue was €79.04 Mil.
Gross Profit was €20.63 Mil.
Total Current Assets was €87.98 Mil.
Total Assets was €92.14 Mil.
Property, Plant and Equipment(Net PPE) was €1.47 Mil.
Depreciation, Depletion and Amortization(DDA) was €0.79 Mil.
Selling, General, & Admin. Expense(SGA) was €24.11 Mil.
Total Current Liabilities was €62.65 Mil.
Long-Term Debt & Capital Lease Obligation was €0.78 Mil.
Net Income was €-8.85 Mil.
Gross Profit was €0.00 Mil.
Cash Flow from Operations was €-13.88 Mil.
 Total Receivables was €23.24 Mil.
Revenue was €81.41 Mil.
Gross Profit was €21.01 Mil.
Total Current Assets was €35.89 Mil.
Total Assets was €39.06 Mil.
Property, Plant and Equipment(Net PPE) was €2.75 Mil.
Depreciation, Depletion and Amortization(DDA) was €1.42 Mil.
Selling, General, & Admin. Expense(SGA) was €27.25 Mil.
Total Current Liabilities was €48.70 Mil.
Long-Term Debt & Capital Lease Obligation was €1.73 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(25.018 / 79.04) / (23.238 / 81.414)
=0.316523 / 0.28543
=1.1089

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(21.012 / 81.414) / (20.632 / 79.04)
=0.258088 / 0.261032
=0.9887

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (87.978 + 1.468) / 92.142) / (1 - (35.885 + 2.745) / 39.058)
=0.029259 / 0.010958
=2.6701

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=79.04 / 81.414
=0.9708

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.42 / (1.42 + 2.745)) / (0.788 / (0.788 + 1.468))
=0.340936 / 0.349291
=0.9761

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(24.11 / 79.04) / (27.254 / 81.414)
=0.305035 / 0.334758
=0.9112

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.781 + 62.654) / 92.142) / ((1.726 + 48.697) / 39.058)
=0.688448 / 1.290978
=0.5333

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-8.85 - 0 - -13.876) / 92.142
=0.054546

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

160 Health International has a M-score of -1.32 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.21 mean?
160 Health International (FRA:O66) has a Beneish M-Score of -1.21 as of Aug. 19, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on 160 Health International and its competitors. According to the industry distribution chart, 160 Health International ranks #105 out of 116 companies in the Medical Distribution industry, placing it in the top 90.5%.
Is 160 Health International's Beneish M-Score too high?
160 Health International's current Beneish M-Score is -1.21. Based on the distribution chart, 160 Health International ranks #105 out of 116 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, 160 Health International has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 160 Health International's Beneish M-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, 160 Health International ranks #105 out of 116 companies for Beneish M-Score. This places 160 Health International in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on 160 Health International and its competitors. 160 Health International's current Beneish M-Score is -1.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 160 Health International stock overvalued right now?
160 Health International (FRA:O66) has a current Beneish M-Score of -1.21. The current Beneish M-Score is -1.21. 160 Health International's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For 160 Health International (FRA:O66), the current Beneish M-Score is -1.21 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

160 Health International Business Description

Other Exchanges 02656:Hong Kong
Address 4078 Dongbin Road, Nanshan Street, 9th, 11th - 12th Floor, Building 2, Yongxin Times Square, Nanshan District, Shenzhen, CHN, 518052
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score

Get the complete analysis for FRA:O66

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.06
Price